{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T16:48:01Z","timestamp":1761238081050},"reference-count":48,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2014,3,27]],"date-time":"2014-03-27T00:00:00Z","timestamp":1395878400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Mol Divers"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1007\/s11030-014-9513-y","type":"journal-article","created":{"date-parts":[[2014,3,26]],"date-time":"2014-03-26T04:48:28Z","timestamp":1395809308000},"page":"637-654","source":"Crossref","is-referenced-by-count":5,"title":["Toward the computer-aided discovery of FabH inhibitors. Do predictive QSAR models ensure high quality virtual screening performance?"],"prefix":"10.1007","volume":"18","author":[{"given":"Yunierkis","family":"P\u00e9rez-Castillo","sequence":"first","affiliation":[]},{"given":"Maykel","family":"Cruz-Monteagudo","sequence":"additional","affiliation":[]},{"given":"Cosmin","family":"Lazar","sequence":"additional","affiliation":[]},{"given":"Jonatan","family":"Taminau","sequence":"additional","affiliation":[]},{"given":"Mathy","family":"Froeyen","sequence":"additional","affiliation":[]},{"given":"Miguel \u00c1ngel","family":"Cabrera-P\u00e9rez","sequence":"additional","affiliation":[]},{"given":"Ann","family":"Now\u00e9","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2014,3,27]]},"reference":[{"key":"9513_CR1","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/j.bcp.2005.11.023","volume":"71","author":"RL Monaghan","year":"2006","unstructured":"Monaghan RL, Barrett JF (2006) Antibacterial drug discovery-then, now and the genomics future. Biochem Pharmacol 71:901\u2013909. doi: 10.1016\/j.bcp.2005.11.023","journal-title":"Biochem Pharmacol"},{"key":"9513_CR2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1146\/annurev.biochem.78.082907.145923","volume":"78","author":"H Nikaido","year":"2009","unstructured":"Nikaido H (2009) Multidrug resistance in bacteria. Annu Rev Biochem 78:119\u2013146. doi: 10.1146\/annurev.biochem.78.082907.145923","journal-title":"Annu Rev Biochem"},{"key":"9513_CR3","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1126\/science.1176667","volume":"325","author":"MA Fischbach","year":"2009","unstructured":"Fischbach MA, Walsh CT (2009) Antibiotics for emerging pathogens. Science 325:1089\u20131093. doi: 10.1126\/science.1176667","journal-title":"Science"},{"key":"9513_CR4","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.coph.2012.07.004","volume":"12","author":"DT Moir","year":"2012","unstructured":"Moir DT, Opperman TJ, Butler MM, Bowlin TL (2012) New classes of antibiotics. Curr Opin Pharmacol 12:535\u2013544. doi: 10.1016\/j.coph.2012.07.004","journal-title":"Curr Opin Pharmacol"},{"key":"9513_CR5","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1271\/bbb.70.1060","volume":"70","author":"H Yoneyama","year":"2006","unstructured":"Yoneyama H, Katsumata R (2006) Antibiotic resistance in bacteria and its future for novel antibiotic development. Biosci Biotechnol Biochem 70:1060\u20131075. doi: 10.1271\/bbb.70.1060","journal-title":"Biosci Biotechnol Biochem"},{"key":"9513_CR6","first-page":"146","volume":"5","author":"RJ Heath","year":"2004","unstructured":"Heath RJ, Rock CO (2004) Fatty acid biosynthesis as a target for novel antibacterials. Curr Opin Investig Drugs 5:146\u2013153","journal-title":"Curr Opin Investig Drugs"},{"key":"9513_CR7","doi-asserted-by":"crossref","first-page":"8695","DOI":"10.1073\/pnas.92.19.8695","volume":"92","author":"A Jayakumar","year":"1995","unstructured":"Jayakumar A, Tai MH, Huang WY, al-Feel W, Hsu M, Abu-Elheiga L, Chirala SS, Wakil SJ (1995) Human fatty acid synthase: properties and molecular cloning. Proc Natl Acad Sci USA 92:8695\u20138699. doi: 10.1073\/pnas.92.19.8695","journal-title":"Proc Natl Acad Sci USA"},{"key":"9513_CR8","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1074\/jbc.271.44.27795","volume":"271","author":"RJ Heath","year":"1996","unstructured":"Heath RJ, Rock CO (1996) Regulation of fatty acid elongation and initiation by acyl\u2013acyl carrier protein in Escherichia coli. J Biol Chem 271:1833\u20131836. doi: 10.1074\/jbc.271.4.1833","journal-title":"J Biol Chem"},{"key":"9513_CR9","doi-asserted-by":"crossref","first-page":"36","DOI":"10.2174\/138955708783331559","volume":"8","author":"Y Perez-Castillo","year":"2008","unstructured":"Perez-Castillo Y, Perez MA (2008) Bacterial beta-ketoacyl-acyl carrier protein synthase III (FabH): an attractive target for the design of new broad-spectrum antimicrobial agents. Mini Rev Med Chem 8:36\u201345. doi: 10.2174\/138955708783331559","journal-title":"Mini Rev Med Chem"},{"key":"9513_CR10","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1021\/jm025571b","volume":"46","author":"RA Daines","year":"2003","unstructured":"Daines RA, Pendrak I, Sham K, Van Aller GS, Konstantinidis AK, Lonsdale JT, Janson CA, Qiu X, Brandt M, Khandekar SS, Silverman C, Head MS (2003) First X-ray cocrystal structure of a bacterial FabH condensing enzyme and a small molecule inhibitor achieved using rational design and homology modeling. J Med Chem 46:5\u20138. doi: 10.1021\/jm025571b","journal-title":"J Med Chem"},{"key":"9513_CR11","doi-asserted-by":"crossref","first-page":"3093","DOI":"10.1128\/AAC.48.8.3093-3102.2004","volume":"48","author":"X He","year":"2004","unstructured":"He X, Reeve AM, Desai UR, Kellogg GE, Reynolds KA (2004) 1,2-Dithiole-3-ones as potent inhibitors of the bacterial 3-ketoacyl acyl carrier protein synthase III (FabH). Antimicrob Agents Chemother 48:3093\u20133102. doi: 10.1128\/AAC.48.8.3093-3102.2004","journal-title":"Antimicrob Agents Chemother"},{"key":"9513_CR12","doi-asserted-by":"crossref","first-page":"6402","DOI":"10.1016\/j.bmcl.2008.10.097","volume":"18","author":"MM Alhamadsheh","year":"2008","unstructured":"Alhamadsheh MM, Waters NC, Sachdeva S, Lee P, Reynolds KA (2008) Synthesis and biological evaluation of novel sulfonyl-naphthalene-1,4-diols as FabH inhibitors. Bioorg Med Chem Lett 18:6402\u20136405. doi: 10.1016\/j.bmcl.2008.10.097","journal-title":"Bioorg Med Chem Lett"},{"key":"9513_CR13","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1021\/jm049141s","volume":"48","author":"Z Nie","year":"2005","unstructured":"Nie Z, Perretta C, Lu J, Su Y, Margosiak S, Gajiwala KS, Cortez J, Nikulin V, Yager KM, Appelt K, Chu S (2005) Structure-based design, synthesis, and study of potent inhibitors of beta-ketoacyl-acyl carrier protein synthase III as potential antimicrobial agents. J Med Chem 48:1596\u20131609. doi: 10.1021\/jm049141s","journal-title":"J Med Chem"},{"key":"9513_CR14","doi-asserted-by":"crossref","first-page":"6264","DOI":"10.1016\/j.bmc.2009.07.046","volume":"17","author":"HQ Li","year":"2009","unstructured":"Li HQ, Shi L, Li QS, Liu PG, Luo Y, Zhao J, Zhu HL (2009) Synthesis of C(7) modified chrysin derivatives designing to inhibit beta-ketoacyl-acyl carrier protein synthase III (FabH) as antibiotics. Bioorg Med Chem 17:6264\u20136269. doi: 10.1016\/j.bmc.2009.07.046","journal-title":"Bioorg Med Chem"},{"key":"9513_CR15","doi-asserted-by":"crossref","first-page":"6750","DOI":"10.1016\/j.bmcl.2009.09.111","volume":"19","author":"PC Lv","year":"2009","unstructured":"Lv PC, Wang KR, Yang Y, Mao WJ, Chen J, Xiong J, Zhu HL (2009) Design, synthesis and biological evaluation of novel thiazole derivatives as potent FabH inhibitors. Bioorg Med Chem Lett 19:6750\u20136754. doi: 10.1016\/j.bmcl.2009.09.111","journal-title":"Bioorg Med Chem Lett"},{"key":"9513_CR16","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1016\/j.bmcl.2010.01.032","volume":"20","author":"HQ Li","year":"2010","unstructured":"Li HQ, Luo Y, Lv PC, Shi L, Liu CH, Zhu HL (2010) Design and synthesis of novel deoxybenzoin derivatives as FabH inhibitors and anti-inflammatory agents. Bioorg Med Chem Lett 20:2025\u20132028. doi: 10.1016\/j.bmcl.2010.01.032","journal-title":"Bioorg Med Chem Lett"},{"key":"9513_CR17","doi-asserted-by":"crossref","first-page":"4657","DOI":"10.1016\/j.bmcl.2010.05.105","volume":"20","author":"PC Lv","year":"2010","unstructured":"Lv PC, Sun J, Luo Y, Yang Y, Zhu HL (2010) Design, synthesis, and structure\u2013activity relationships of pyrazole derivatives as potential FabH inhibitors. Bioorg Med Chem Lett 20:4657\u20134660. doi: 10.1016\/j.bmcl.2010.05.105","journal-title":"Bioorg Med Chem Lett"},{"key":"9513_CR18","doi-asserted-by":"crossref","first-page":"4358","DOI":"10.1016\/j.ejmech.2010.05.033","volume":"45","author":"L Shi","year":"2010","unstructured":"Shi L, Fang RQ, Zhu ZW, Yang Y, Cheng K, Zhong WQ, Zhu HL (2010) Design and synthesis of potent inhibitors of beta-ketoacyl-acyl carrier protein synthase III (FabH) as potential antibacterial agents. Eur J Med Chem 45:4358\u20134364. doi: 10.1016\/j.ejmech.2010.05.033","journal-title":"Eur J Med Chem"},{"key":"9513_CR19","doi-asserted-by":"crossref","first-page":"4454","DOI":"10.1016\/j.bmc.2011.06.048","volume":"19","author":"HQ Li","year":"2011","unstructured":"Li HQ, Luo Y, Zhu HL (2011) Discovery of vinylogous carbamates as a novel class of beta-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors. Bioorg Med Chem 19:4454\u20134459. doi: 10.1016\/j.bmc.2011.06.048","journal-title":"Bioorg Med Chem"},{"key":"9513_CR20","doi-asserted-by":"crossref","first-page":"4413","DOI":"10.1016\/j.bmc.2011.06.049","volume":"19","author":"ZL Li","year":"2011","unstructured":"Li ZL, Li QS, Zhang HJ, Hu Y, Zhu DD, Zhu HL (2011) Design, synthesis and biological evaluation of urea derivatives from o-hydroxybenzylamines and phenylisocyanate as potential FabH inhibitors. Bioorg Med Chem 19:4413\u20134420. doi: 10.1016\/j.bmc.2011.06.049","journal-title":"Bioorg Med Chem"},{"key":"9513_CR21","doi-asserted-by":"crossref","first-page":"5708","DOI":"10.1016\/j.bmc.2011.06.077","volume":"19","author":"HJ Zhang","year":"2011","unstructured":"Zhang HJ, Qin X, Liu K, Zhu DD, Wang XM, Zhu HL (2011) Synthesis, antibacterial activities and molecular docking studies of Schiff bases derived from N-(2\/4-benzaldehyde-amino) phenyl-N\u2019-phenyl-thiourea. Bioorg Med Chem 19:5708\u20135715. doi: 10.1016\/j.bmc.2011.06.077","journal-title":"Bioorg Med Chem"},{"key":"9513_CR22","doi-asserted-by":"crossref","first-page":"4513","DOI":"10.1016\/j.bmc.2011.06.021","volume":"19","author":"HJ Zhang","year":"2011","unstructured":"Zhang HJ, Zhu DD, Li ZL, Sun J, Zhu HL (2011) Synthesis, molecular modeling and biological evaluation of beta-ketoacyl-acyl carrier protein synthase III (FabH) as novel antibacterial agents. Bioorg Med Chem 19:4513\u20134519. doi: 10.1016\/j.bmc.2011.06.021","journal-title":"Bioorg Med Chem"},{"key":"9513_CR23","doi-asserted-by":"crossref","first-page":"4316","DOI":"10.1016\/j.bmc.2012.05.050","volume":"20","author":"Y Li","year":"2012","unstructured":"Li Y, Luo Y, Hu Y, Zhu DD, Zhang S, Liu ZJ, Gong HB, Zhu HL (2012) Design, synthesis and antimicrobial activities of nitroimidazole derivatives containing 1,3,4-oxadiazole scaffold as FabH inhibitors. Bioorg Med Chem 20:4316\u20134322. doi: 10.1016\/j.bmc.2012.05.050","journal-title":"Bioorg Med Chem"},{"key":"9513_CR24","doi-asserted-by":"crossref","first-page":"4619","DOI":"10.1016\/j.bmcl.2012.05.091","volume":"22","author":"YS Yang","year":"2012","unstructured":"Yang YS, Zhang F, Gao C, Zhang YB, Wang XL, Tang JF, Sun J, Gong HB, Zhu HL (2012) Discovery and modification of sulfur-containing heterocyclic pyrazoline derivatives as potential novel class of beta-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors. Bioorg Med Chem Lett 22:4619\u20134624. doi: 10.1016\/j.bmcl.2012.05.091","journal-title":"Bioorg Med Chem Lett"},{"key":"9513_CR25","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1080\/14756360600920149","volume":"22","author":"A Ashek","year":"2007","unstructured":"Ashek A, San Juan AA (2007) HQSAR study of beta-ketoacyl-acyl carrier protein synthase III (FabH) inhibitors. J Enzyme Inhib Med Chem 22:7\u201314. doi: 10.1080\/14756360600920149","journal-title":"J Enzyme Inhib Med Chem"},{"key":"9513_CR26","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.ejmech.2007.06.018","volume":"43","author":"S Singh","year":"2008","unstructured":"Singh S, Soni LK, Gupta MK, Prabhakar YS, Kaskhedikar SG (2008) QSAR studies on benzoylaminobenzoic acid derivatives as inhibitors of beta-ketoacyl-acyl carrier protein synthase III. Eur J Med Chem 43:1071\u20131080. doi: 10.1016\/j.ejmech.2007.06.018","journal-title":"Eur J Med Chem"},{"key":"9513_CR27","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s10822-011-9427-z","volume":"25","author":"Y Perez-Castillo","year":"2011","unstructured":"Perez-Castillo Y, Froeyen M, Cabrera-Perez MA, Nowe A (2011) Molecular dynamics and docking simulations as a proof of high flexibility in E. coli FabH and its relevance for accurate inhibitor modeling. J Comput Aided Mol Des 25:371\u2013393. doi: 10.1007\/s10822-011-9427-z","journal-title":"J Comput Aided Mol Des"},{"key":"9513_CR28","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1021\/ci300421n","volume":"53","author":"L Zhang","year":"2013","unstructured":"Zhang L, Fourches D, Sedykh A, Zhu H, Golbraikh A, Ekins S, Clark J, Connelly MC, Sigal M, Hodges D, Guiguemde A, Guy RK, Tropsha A (2013) Discovery of novel antimalarial compounds enabled by QSAR-based virtual screening. J Chem Inf Model 53:475\u2013492. doi: 10.1021\/ci300421n","journal-title":"J Chem Inf Model"},{"key":"9513_CR29","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1021\/ci100176x","volume":"50","author":"D Fourches","year":"2010","unstructured":"Fourches D, Muratov E, Tropsha A (2010) Trust, but verify: on the importance of chemical structure curation in cheminformatics and QSAR modeling research. J Chem Inf Model 50:1189\u20131204. doi: 10.1021\/ci100176x","journal-title":"J Chem Inf Model"},{"key":"9513_CR30","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/minf.201000061","volume":"29","author":"A Tropsha","year":"2010","unstructured":"Tropsha A (2010) Best practices for QSAR model development, validation, and exploitation. Mol Inf 29:476\u2013488. doi: 10.1002\/minf.201000061","journal-title":"Mol Inf"},{"key":"9513_CR31","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1021\/jm9700878","volume":"41","author":"T Potter","year":"1998","unstructured":"Potter T, Matter H (1998) Random or rational design? Evaluation of diverse compound subsets from chemical structure databases. J Med Chem 41:478\u2013488. doi: 10.1021\/jm9700878","journal-title":"J Med Chem"},{"key":"9513_CR32","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1023\/A:1021372108686","volume":"5","author":"A Golbraikh","year":"2000","unstructured":"Golbraikh A, Tropsha A (2000) Predictive QSAR modeling based on diversity sampling of experimental datasets for the training and test set selection. Mol Divers 5:231\u2013243. doi: 10.1023\/A:1021372108686","journal-title":"Mol Divers"},{"key":"9513_CR33","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s11030-013-9447-9","volume":"17","author":"X Hou","year":"2013","unstructured":"Hou X, Yan A (2013) Classification of Plasmodium falciparum glucose-6-phosphate dehydrogenase inhibitors by support vector machine. Mol Divers 17:489\u2013497. doi: 10.1007\/s11030-013-9447-9","journal-title":"Mol Divers"},{"key":"9513_CR34","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1021\/ci600426e","volume":"47","author":"JF Truchon","year":"2007","unstructured":"Truchon JF, Bayly CI (2007) Evaluating virtual screening methods: good and bad metrics for the \u201dearly recognition\u201d problem. J Chem Inf Model 47:488\u2013508. doi: 10.1021\/ci600426e","journal-title":"J Chem Inf Model"},{"key":"9513_CR35","doi-asserted-by":"crossref","unstructured":"Scior T, Bender A, Tresadern G, Medina-Franco JL, Martinez-Mayorga K, Langer T, Cuanalo-Contreras K, Agrafiotis DK (2012) Recognizing pitfalls in virtual screening: a critical review. J Chem Inf Model. doi: 10.1021\/ci200528d","DOI":"10.1021\/ci200528d"},{"key":"9513_CR36","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10822-007-9163-6","volume":"22","author":"J Kirchmair","year":"2008","unstructured":"Kirchmair J, Markt P, Distinto S, Wolber G, Langer T (2008) Evaluation of the performance of 3D virtual screening protocols: RMSD comparisons, enrichment assessments, and decoy selection\u2013What can we learn from earlier mistakes? J Comput Aided Mol Des 22:213\u2013228. doi: 10.1007\/s10822-007-9163-6","journal-title":"J Comput Aided Mol Des"},{"key":"9513_CR37","first-page":"327","volume":"11","author":"A Bender","year":"2008","unstructured":"Bender A, Bojanic D, Davies JW, Crisman TJ, Mikhailov D, Scheiber J, Jenkins JL, Deng Z, Hill WA, Popov M, Jacoby E, Glick M (2008) Which aspects of HTS are empirically correlated with downstream success? Curr Opin Drug Discov Devel 11:327\u2013337","journal-title":"Curr Opin Drug Discov Devel"},{"key":"9513_CR38","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.ejmech.2012.10.035","volume":"59","author":"AM Helguera","year":"2013","unstructured":"Helguera AM, P\u00e9rez-Garrido A, Gaspar A, Reis J, Cagide F, Vina D, Cordeiro MNDS, Borges F (2013) Combining QSAR classification models for predictive modeling of human monoamine oxidase inhibitors. Eur J Med Chem 59:75\u201390. doi: 10.1016\/j.ejmech.2012.10.035","journal-title":"Eur J Med Chem"},{"key":"9513_CR39","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s11030-010-9234-9","volume":"15","author":"M Fernandez","year":"2011","unstructured":"Fernandez M, Caballero J, Fernandez L, Sarai A (2011) Genetic algorithm optimization in drug design QSAR: Bayesian-regularized genetic neural networks (BRGNN) and genetic algorithm-optimized support vectors machines (GA-SVM). Mol Divers 15:269\u2013289. doi: 10.1007\/s11030-010-9234-9","journal-title":"Mol Divers"},{"key":"9513_CR40","unstructured":"ChemAxon (2012) J Chem. 5.9.0 edn."},{"key":"9513_CR41","doi-asserted-by":"crossref","unstructured":"Varnek A, Fourches D, Horvath D, Klimchuk O, Gaudin C, Vayer P, Solov, ev V, Hoonakker F, Tetko IV, Marcou G (2008) ISIDA\u2014platform for virtual screening based on fragment and pharmacophoric descriptors. Curr Comput Aided Drug Des 4:191\u2013198. doi: 10.2174\/157340908785747465","DOI":"10.2174\/157340908785747465"},{"key":"9513_CR42","unstructured":"Talete (2010) DRAGON (Software for Molecular Descriptor Calculation). 6.0 edn."},{"key":"9513_CR43","unstructured":"MATLAB (2009). R2009a edn. The MathWorks Inc."},{"key":"9513_CR44","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1021\/ci300146h","volume":"52","author":"Y Perez-Castillo","year":"2012","unstructured":"Perez-Castillo Y, Lazar C, Taminau J, Froeyen M, Cabrera-Perez MA, Nowe A (2012) GA(M)E-QSAR: a novel, fully automatic genetic-algorithm-(meta)-ensembles approach for binary classification in ligand-based drug design. J Chem Inf Model 52:2366\u20132386. doi: 10.1021\/ci300146h","journal-title":"J Chem Inf Model"},{"key":"9513_CR45","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1177\/026119290503300508","volume":"33","author":"J Jaworska","year":"2005","unstructured":"Jaworska J, Nikolova-Jeliazkova N, Aldenberg T (2005) QSAR applicabilty domain estimation by projection of the training set descriptor space: a review. Altern Lab Anim 33:445\u2013459","journal-title":"Altern Lab Anim"},{"key":"9513_CR46","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1021\/ci3001277","volume":"52","author":"JJ Irwin","year":"2012","unstructured":"Irwin JJ, Sterling T, Mysinger MM, Bolstad ES, Coleman RG (2012) ZINC: a free tool to discover chemistry for biology. J Chem Inf Model 52:1757\u20131768. doi: 10.1021\/ci3001277","journal-title":"J Chem Inf Model"},{"key":"9513_CR47","doi-asserted-by":"crossref","first-page":"6789","DOI":"10.1021\/jm0608356","volume":"49","author":"N Huang","year":"2006","unstructured":"Huang N, Shoichet BK, Irwin JJ (2006) Benchmarking sets for molecular docking. J Med Chem 49:6789\u20136801. doi: 10.1021\/jm0608356","journal-title":"J Med Chem"},{"key":"9513_CR48","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1002\/j.1538-7305.1950.tb00463.x","volume":"26","author":"R Hamming","year":"1950","unstructured":"Hamming R (1950) Error detecting and error correcting codes. Bell Syst Tech J 26:147\u2013160. doi: 10.1002\/j.1538-7305.1950.tb00463.x","journal-title":"Bell Syst Tech J"}],"container-title":["Molecular Diversity"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-014-9513-y.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11030-014-9513-y\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11030-014-9513-y","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T22:49:38Z","timestamp":1565304578000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11030-014-9513-y"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,3,27]]},"references-count":48,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["9513"],"URL":"https:\/\/doi.org\/10.1007\/s11030-014-9513-y","relation":{},"ISSN":["1381-1991","1573-501X"],"issn-type":[{"value":"1381-1991","type":"print"},{"value":"1573-501X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2014,3,27]]}}}